from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1159/pimE

LFCtreatmentdescriptionclass of inhibitor

0.486

Amikacinug/mL Amikacintranslation

-0.414

Cap5-10ug/mL Capreomycintranslation

-0.515

Rox10-50 ug/mL Roxithromycintranslation

-0.308

SM2-5 ug/mL Streptomycintranslation

-1.160

Tet5-10 ug/mL Tetracyclinetranslation

1.394

Rif0.2-5ug/mL Rifampicintranscription

0.383

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.100

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.941

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.096

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.225

Clofazimine10-13 ug/mL Clofaziminerespiration

0.483

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.190

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.268

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.296

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.190

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.442

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.421

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.557

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.273

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.153

KCN5-20 ug/mL Potassium cyaniderespiration

0.356

NaN30.2-2 mM Sodium aziderespiration

-0.474

Nigericin50 uM Nigericinrespiration

0.060

TRC10-150 ug/mL Triclosanrespiration

-0.539

TRZ10-25 ug/mL Thioridazinerespiration

-1.700

Valinomycin0.5-10 uM Valinomycinrespiration

-1.047

ZnSO42 mM ZnSO4respiration

-0.665

menadione6-10 ug/mL Menadionerespiration

0.666

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.084

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.129

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.506

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.789

NRP_1Non-replicating persistence stage 1dosRassociated

-0.844

Amp0.2mg/mL AmpicillincellWall

-0.357

Cephalexin20-100 ug/mL CephalexincellWall

0.310

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.381

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.370

EMB10-20 ug/mL EthambutolcellWall

0.286

Eta12-40 ug/mL EthionamidecellWall

0.344

INH0.2-0.4 ug/mL IsoniazidcellWall

0.340

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.783

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.740

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.467

BZA0.12 mg/mL BenzamidearomaticAmides

-0.459

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.210

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.343

H2O24 mM hydrogen peroxideDNAdamaging

0.713

Levo10 ug/mL LevofloxacinDNAdamaging

-0.937

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.004

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.009

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.540

UVUV-irradiationDNAdamaging

0.969

ARP41-4 ug/mL Antitubercular compound ARP4?

0.112

Antimycin12.5-50 ug/mL Antimycin A?

-0.204

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.386

PA_110-50 ug/mL Antitubercular compound PA-1?

0.117

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.566

PA8240.2-2 ug/mL PA-824?

0.487

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.717

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.411

Verapamil50 uM Verapamil?

0.216

mercaptoethanol2 mM 2-Mercaptoethanol?

0.191

methoxatin10-20 ug/mL Methoxatin?